Drug Profile
NS 49
Alternative Names: ABT 232; PNO 49BLatest Information Update: 24 Jan 2013
Price :
$50
*
At a glance
- Originator Nippon Shinyaku
- Developer Abbott Laboratories; Nippon Shinyaku; Sanofi-Synthelabo
- Class Anilides; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stress incontinence; Urinary incontinence
Most Recent Events
- 09 Mar 2001 Discontinued-II for Stress incontinence in USA (Unknown route)
- 09 Mar 2001 Discontinued-II for Urinary incontinence in European Union (Unknown route)
- 09 Mar 2001 Discontinued-II for Urinary incontinence in Japan (Unknown route)